IL10 and marginal zone lymphoma: In future studies, we aim to collect adequate blood and tissue samples from MZL patients and use ELISA, qPCR, and immunohistochemistry to detect and compare the levels of MIG, IL-10, B-NGF, and IFN-γ in these samples versus healthy controls.